企業プロフィール · Healthcare

Abbott Laboratories

ABT · 米国株
取引所
米国株
国 / 地域
USA
上場日
1978年1月13日
従業員数
122,000
公式サイト
www.abbott.com
現在値
$88.41
リアルタイム · 2026年6月18日
ベイリー成長スコア
47/100
やや弱い
本源的価値 · 3 段階レンジ 現在値 $88.41 リアルタイム · 保守的レンジと妥当レンジの間

総合バリュエーションレンジ · 保守的 $70–$85 / 妥当 $90–$105 / 楽観的 $115–$135。$88.41 時点で 保守的レンジと妥当レンジの間。

レポート公開時 $88.38(2026年5月21日)

この銘柄のレポートはお使いの言語でまだありません。

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company offers generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, hypertriglyceridemia, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also provides laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion serology testing; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; and drug and alcohol test. In addition, the company offers pediatric and adult nutritional products and infant formula; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices. The company was formerly known as Abbott Alkaloidal Company and changed its name to Abbott Laboratories in 1915. Abbott Laboratories was founded in 1888 and is based in Abbott Park, Illinois.

時価総額$1541.5億
売上高(TTM)$451.34億
EBITDA$117.44億
純利益率13.9%
ROE12.33%
PER (TTM)24.79
予想PER16.53
PEG1.34
EPS$3.57
配当利回り2.69%
52週レンジ$81.97 – $136.28
アナリスト目標株価$116.54
アナリスト評価4.3 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

沿革

近日公開このセクションは現在準備中です。近日公開予定です。

業界での地位

近日公開このセクションは現在準備中です。近日公開予定です。